Cash flow Merck & Co., Inc.

Equities

MRK

US58933Y1055

Pharmaceuticals

Market Closed - Nyse Other stock markets 01:30:50 19/05/2026 am IST			5-day change	1st Jan Change
112.56 ^USD	+1.06%		+1.15%	+6.94%

18/05	Global markets live: Merck, Regeneron, Ford, Lululemon, Brambles…
18/05	Regeneron drops after skin cancer treatment fails late-stage trial	RE

b2e8e0eadd5ffdde601fe18416f763bd.H2Z6dDzBm31txVFXbFaWAF3CFv2LAJ1FoJt4hLaGvn0.fgwWEVeH6i0f6GMZHhjmcRi2Vb7hLdsaz9dL24O28Rh2IRwNSfP3NFmXYQ

Published financial data: MERCK & CO., INC.

Annual

Quarterly

Halfyear

YTD

LTM

Fiscal Period: December	2021	2022	2023	2024	2025
Revenues	4.87TCr	5.93TCr	6.01TCr	6.42TCr	6.5TCr
Total Revenues	4.87TCr	5.93TCr	6.01TCr	6.42TCr	6.5TCr
Cost of Goods Sold, Total	1.32TCr	1.72TCr	1.59TCr	1.47TCr	1.48TCr
Gross Profit	3.55TCr	4.21TCr	4.42TCr	4.95TCr	5.02TCr
Selling General & Admin Expenses, Total	940.3Cr	966.9Cr	988.4Cr	1.01TCr	1.01TCr
R&D Expenses	1.02TCr	1.18TCr	1.83TCr	1.45TCr	1.56TCr
Other Operating Expenses, Total	1.96TCr	2.15TCr	2.82TCr	2.46TCr	2.57TCr
Operating Income	1.59TCr	2.06TCr	1.6TCr	2.49TCr	2.45TCr
Interest Expense, Total	-81Cr	-96Cr	-114.6Cr	-127.1Cr	-135.7Cr
Interest And Investment Income	3.6Cr	31Cr	36Cr	42Cr	34Cr
Net Interest Expenses	-77Cr	-65Cr	-78Cr	-86Cr	-101.4Cr
Income (Loss) On Equity Invest.	-	-	-	-	-
Currency Exchange Gains (Loss)	-30Cr	-24Cr	-37Cr	-23Cr	-32Cr
Other Non Operating Income (Expenses)	26Cr	52Cr	42Cr	29Cr	20Cr
EBT, Excl. Unusual Items	1.5TCr	2.02TCr	1.52TCr	2.41TCr	2.33TCr
Restructuring Charges	-87Cr	-67Cr	-93Cr	-89Cr	-255.1Cr
Merger & Related Restructuring Charges	-170.4Cr	-	-1.14TCr	-345.6Cr	-8.3Cr
Impairment of Goodwill	-	-	-	-	-
Gain (Loss) On Sale Of Investments	194Cr	-141.9Cr	34Cr	1.4Cr	37Cr
Asset Writedown	-28Cr	-160Cr	-78Cr	-	-
Legal Settlements	-	-	-57Cr	-	-
Other Unusual Items	-26Cr	-7.5Cr	-	17Cr	-
EBT, Incl. Unusual Items	1.39TCr	1.64TCr	188.9Cr	1.99TCr	2.11TCr
Income Tax Expense	152.1Cr	191.8Cr	151.2Cr	280.3Cr	280.4Cr
Earnings From Continuing Operations	1.24TCr	1.45TCr	38Cr	1.71TCr	1.83TCr
Earnings Of Discontinued Operations	70Cr	-	-	-	-
Net Income to Company	1.31TCr	1.45TCr	38Cr	1.71TCr	1.83TCr
Minority Interest	-1.3Cr	-70L	-1.2Cr	-1.6Cr	-90L
Net Income - (IS)	1.3TCr	1.45TCr	36Cr	1.71TCr	1.83TCr
Net Income to Common Incl Extra Items	1.3TCr	1.45TCr	36Cr	1.71TCr	1.83TCr
Net Income to Common Excl. Extra Items	1.23TCr	1.45TCr	36Cr	1.71TCr	1.83TCr
Per Share Items
Net EPS - Basic	5.16	5.73	0.14	6.76	7.3
Basic EPS - Continuing Operations	4.88	5.73	0.14	6.76	7.3
Basic Weighted Average Shares Outstanding	253Cr	253.2Cr	253.7Cr	253.2Cr	250.2Cr
Net EPS - Diluted	5.14	5.71	0.14	6.74	7.28
Diluted EPS - Continuing Operations	4.86	5.71	0.14	6.74	7.28
Diluted Weighted Average Shares Outstanding	253.8Cr	254.2Cr	254.7Cr	254.1Cr	250.7Cr
Normalized Basic EPS	3.71	4.98	3.75	5.94	5.82
Normalized Diluted EPS	3.7	4.96	3.74	5.92	5.81
Dividend Per Share	2.6	2.76	2.92	3.08	3.24
Payout Ratio	50.66	48.3	2.04T	45.8	44.79
American Depositary Receipts Ratio (ADR)	0.12	0.12	0.12	0.12	0.12
Supplemental Items
EBITDA	1.9TCr	2.44TCr	1.97TCr	2.91TCr	2.91TCr
EBITA	1.75TCr	2.26TCr	1.8TCr	2.73TCr	2.73TCr
EBIT	1.59TCr	2.06TCr	1.6TCr	2.49TCr	2.45TCr
EBITDAR	1.93TCr	2.47TCr	2TCr	2.95TCr	2.95TCr
Effective Tax Rate - (Ratio)	10.96	11.66	80.04	14.06	13.31
Current Domestic Taxes	6.1Cr	232.2Cr	98Cr	93Cr	40Cr
Current Foreign Taxes	127.3Cr	116.4Cr	243.5Cr	312.3Cr	407.2Cr
Total Current Taxes	133.4Cr	348.6Cr	341.1Cr	405.2Cr	447.5Cr
Deferred Domestic Taxes	26Cr	-163.9Cr	-166.6Cr	-146.1Cr	-158.8Cr
Deferred Foreign Taxes	-7.7Cr	7.1Cr	-23Cr	21Cr	-8.3Cr
Total Deferred Taxes	19Cr	-156.8Cr	-189.9Cr	-124.9Cr	-167.1Cr
Normalized Net Income	939.08Cr	1.26TCr	951.49Cr	1.5TCr	1.46TCr
Non-Cash Pension Expense	1.7Cr	-10Cr	-40Cr	-51Cr	-54Cr
Supplemental Operating Expense Items
Advertising Expense	200Cr	220Cr	230Cr	240Cr	230Cr
Selling and Marketing Expenses	200Cr	220Cr	230Cr	240Cr	230Cr
Research And Development Expense From Footnotes	1.22TCr	1.35TCr	3.05TCr	1.79TCr	1.58TCr
Net Rental Expense, Total	34Cr	33Cr	34Cr	35Cr	42Cr
Imputed Operating Lease Interest Expense	6.5Cr	7.72Cr	9.11Cr	9.49Cr	10Cr
Imputed Operating Lease Depreciation	28Cr	26Cr	25Cr	25Cr	32Cr
Stock-Based Comp., Other (Total)	48Cr	54Cr	64Cr	76Cr	82Cr
Total Stock-Based Compensation	48Cr	54Cr	64Cr	76Cr	82Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Assets
Cash And Equivalents	809.6Cr	1.27TCr	684.1Cr	1.32TCr	1.46TCr
Short Term Investments	-	50Cr	25Cr	45Cr	-
Trading Asset Securities, Total	1.4Cr	-	-	-	-
Total Cash And Short Term Investments	811Cr	1.32TCr	709.3Cr	1.37TCr	1.46TCr
Accounts Receivable, Total	1.08TCr	1.06TCr	1.17TCr	1.11TCr	1.27TCr
Other Receivables	-	-	-	80L	1.5Cr
Total Receivables	1.08TCr	1.06TCr	1.17TCr	1.11TCr	1.27TCr
Inventory	595.3Cr	591.1Cr	635.8Cr	610.9Cr	665.8Cr
Restricted Cash	-	7.9Cr	6.8Cr	7.6Cr	12Cr
Other Current Assets, Total	542.4Cr	591.9Cr	694.5Cr	778.1Cr	946.2Cr
Total Current Assets	3.03TCr	3.57TCr	3.22TCr	3.88TCr	4.35TCr
Gross Property Plant And Equipment	3.91TCr	4.08TCr	4.28TCr	4.43TCr	4.87TCr
Accumulated Depreciation	-1.82TCr	-1.8TCr	-1.83TCr	-1.92TCr	-2.19TCr
Net Property Plant And Equipment	2.09TCr	2.28TCr	2.45TCr	2.51TCr	2.68TCr
Long-term Investments	97Cr	184.7Cr	155.8Cr	161Cr	208.2Cr
Goodwill	2.13TCr	2.12TCr	2.12TCr	2.17TCr	2.16TCr
Other Intangibles, Total	2.29TCr	2.03TCr	1.8TCr	1.64TCr	2.67TCr
Accounts Receivable Long-Term	-	-	-	-	12Cr
Deferred Tax Assets Long-Term	69Cr	50Cr	196.8Cr	360.1Cr	260.5Cr
Other Long-Term Assets, Total	870.8Cr	684.7Cr	728.5Cr	992.6Cr	1.35TCr
Total Assets	11TCr	11TCr	11TCr	12TCr	14TCr
Liabilities
Accounts Payable, Total	638.9Cr	503.7Cr	496.9Cr	499.9Cr	451.5Cr
Accrued Expenses, Total	1.15TCr	1.26TCr	1.42TCr	1.39TCr	1.37TCr
Short-term Borrowings	11Cr	25Cr	7.2Cr	15Cr	29Cr
Current Portion of Long-Term Debt	230Cr	170Cr	130Cr	250Cr	230Cr
Current Portion of Leases	30Cr	28Cr	28Cr	28Cr	29Cr
Current Income Taxes Payable	122.4Cr	198.6Cr	264.9Cr	391.4Cr	472.6Cr
Other Current Liabilities	205.2Cr	235.8Cr	222.6Cr	270.6Cr	246.3Cr
Total Current Liabilities	2.39TCr	2.42TCr	2.57TCr	2.84TCr	2.83TCr
Long-Term Debt	3.07TCr	2.87TCr	3.37TCr	3.45TCr	4.68TCr
Long-Term Leases	122.5Cr	101.3Cr	93Cr	88Cr	90Cr
Pension & Other Post Retirement Benefits	187.1Cr	122.3Cr	123.1Cr	94Cr	84Cr
Deferred Tax Liability Non Current	344.1Cr	179.5Cr	87Cr	138.7Cr	143.9Cr
Other Non Current Liabilities	633.8Cr	608.7Cr	663.3Cr	464.9Cr	594.8Cr
Total Liabilities	6.74TCr	6.31TCr	6.9TCr	7.07TCr	8.42TCr
Common Stock, Total	178.8Cr	178.8Cr	178.8Cr	178.8Cr	178.8Cr
Additional Paid In Capital	4.42TCr	4.44TCr	4.45TCr	4.47TCr	4.5TCr
Retained Earnings	5.37TCr	6.11TCr	5.39TCr	6.31TCr	7.31TCr
Treasury Stock	-5.71TCr	-5.65TCr	-5.74TCr	-5.83TCr	-6.3TCr
Comprehensive Income and Other	-442.9Cr	-476.8Cr	-516.1Cr	-494.5Cr	-428.7Cr
Total Common Equity	3.82TCr	4.6TCr	3.76TCr	4.63TCr	5.26TCr
Minority Interest	7.3Cr	6.7Cr	5.4Cr	5.9Cr	5.6Cr
Total Equity	3.83TCr	4.61TCr	3.76TCr	4.64TCr	5.27TCr
Total Liabilities And Equity	11TCr	11TCr	11TCr	12TCr	14TCr
Supplemental Items
ECS Total Shares Outstanding on Filing Date	252.77Cr	253.86Cr	253.26Cr	252.6Cr	247.24Cr
ECS Total Common Shares Outstanding	252.76Cr	253.78Cr	253.16Cr	252.76Cr	247.46Cr
Book Value / Share	15.11	18.12	14.84	18.32	21.26
Tangible Book Value	-601.3Cr	451.8Cr	-162.7Cr	827.5Cr	434.6Cr
Tangible Book Value Per Share	-2.38	1.78	-0.64	3.27	1.76
Total Debt	3.46TCr	3.2TCr	3.63TCr	3.83TCr	5.05TCr
Net Debt	2.65TCr	1.88TCr	2.92TCr	2.46TCr	3.6TCr
Debt Equivalent of Unfunded Proj. Benefit Obligation	31Cr	4.2Cr	12Cr	-94Cr	-258.6Cr
Debt Equivalent Oper. Leases	274.4Cr	267.2Cr	271.2Cr	278.4Cr	338.4Cr
Minority Interest, Total (Incl. Fin. Div)	7.3Cr	6.7Cr	5.4Cr	5.9Cr	5.6Cr
Equity Method Investments, Total	-	-	-	-	-
Account Code - Inventory Valuation	4	4	4	4	4
LIFO Reserve, Total	-1.6Cr	-29Cr	-56Cr	-84Cr	-91Cr
Inventories - Raw Materials, Total	402.6Cr	412.5Cr	468.9Cr	463.8Cr	496.4Cr
Inventories - Finished Goods, Total	174.7Cr	184.1Cr	195.4Cr	202.2Cr	227.5Cr
Inventories - Others	20Cr	24Cr	28Cr	29Cr	33Cr
Land - (BS)	33Cr	30Cr	33Cr	31Cr	32Cr
Buildings, Total	1.25TCr	1.32TCr	1.5TCr	1.64TCr	1.8TCr
Machinery, Total	1.63TCr	1.68TCr	1.78TCr	1.83TCr	1.98TCr
Full Time Employees	67T	67T	70T	73T	73T
Part Time Employees	1T	2T	2T	2T	2T
Accumulated Allowance for Doubtful Accounts (Supple)	6.2Cr	7.2Cr	8.8Cr	8.9Cr	9.7Cr

Fiscal Period: December	2021	2022	2023	2024	2025
Net Income	1.3TCr	1.45TCr	36Cr	1.71TCr	1.83TCr
Depreciation & Amortization - CF	148.7Cr	170.4Cr	168.8Cr	185Cr	184.5Cr
Amortization of Goodwill and Intangible Assets - (CF)	163.6Cr	208.5Cr	204.4Cr	239.5Cr	279.3Cr
Depreciation & Amortization, Total	312.3Cr	378.9Cr	373.2Cr	424.5Cr	463.8Cr
Asset Writedown & Restructuring Costs	39Cr	186.9Cr	93Cr	29Cr	125.5Cr
(Income) Loss On Equity Investments - (CF)	-194Cr	141.9Cr	-34Cr	-1.4Cr	-37Cr
Stock-Based Compensation (CF)	48Cr	54Cr	64Cr	76Cr	82Cr
Net Cash From Discontinued Operations	99Cr	-	-	-	-
Other Operating Activities, Total	185.7Cr	-26Cr	987.7Cr	273.3Cr	-115.1Cr
Change In Accounts Receivable	-203.3Cr	-64Cr	-114.8Cr	-24Cr	-109Cr
Change In Inventories	-67Cr	-16Cr	-82Cr	-84Cr	-118Cr
Change In Accounts Payable	40Cr	-29Cr	-38Cr	18Cr	11Cr
Change In Income Taxes	-54Cr	38Cr	21Cr	102.3Cr	14Cr
Change in Other Net Operating Assets	-100Cr	-206.8Cr	-7.5Cr	-379.3Cr	-495.3Cr
Cash from Operations	1.41TCr	1.91TCr	1.3TCr	2.15TCr	1.65TCr
Capital Expenditure	-444.8Cr	-438.8Cr	-386.3Cr	-337.2Cr	-411.2Cr
Cash Acquisitions	-1.29TCr	-12Cr	-1.2TCr	-409.3Cr	-1TCr
Investment in Marketable and Equity Securities, Total	102.5Cr	-48Cr	184.8Cr	-14Cr	47Cr
Other Investing Activities, Total	-22Cr	3.2Cr	-3.6Cr	-13Cr	-5.8Cr
Cash from Investing	-1.66TCr	-496Cr	-1.41TCr	-773.4Cr	-1.37TCr
Short Term Debt Issued, Total	-	-	-	-	-
Long-Term Debt Issued, Total	793.6Cr	-	593.9Cr	359.9Cr	1.39TCr
Total Debt Issued	793.6Cr	-	593.9Cr	359.9Cr	1.39TCr
Short Term Debt Repaid, Total	-398.6Cr	-	-	-	-
Long-Term Debt Repaid, Total	-231.9Cr	-225.1Cr	-175.5Cr	-129Cr	-250.3Cr
Total Debt Repaid	-630.5Cr	-225.1Cr	-175.5Cr	-129Cr	-250.3Cr
Issuance of Common Stock	20Cr	38Cr	12Cr	18Cr	9.2Cr
Repurchase of Common Stock	-84Cr	-	-134.6Cr	-130.6Cr	-508.4Cr
Common Dividends Paid	-661Cr	-701.2Cr	-744.5Cr	-784Cr	-817.6Cr
Common & Preferred Stock Dividends Paid	-661Cr	-701.2Cr	-744.5Cr	-784Cr	-817.6Cr
Other Financing Activities, Total	821Cr	-24Cr	-33Cr	-37Cr	-13Cr
Cash from Financing	259.3Cr	-911.9Cr	-481Cr	-703.2Cr	-192.2Cr
Foreign Exchange Rate Adjustments	-13Cr	-41Cr	2.3Cr	-29Cr	56Cr
Net Change in Cash	1.4Cr	460.6Cr	-586.4Cr	640.9Cr	137.2Cr
Supplemental Items
Cash Interest Paid	78Cr	94Cr	110Cr	130Cr	130Cr
Cash Income Tax Paid (Refund)	240Cr	320Cr	433.8Cr	392.8Cr	608.6Cr
Levered Free Cash Flow	666.89Cr	1.27TCr	926.15Cr	1.78TCr	1.19TCr
Unlevered Free Cash Flow	717.26Cr	1.33TCr	997.78Cr	1.86TCr	1.27TCr
Change In Net Working Capital	189.2Cr	-50Cr	52Cr	-143.4Cr	390.3Cr
Net Debt Issued / Repaid	163.1Cr	-225.1Cr	418.4Cr	230.9Cr	1.14TCr

Fiscal Period: December	2021	2022	2023	2024	2025
Profitability
Return on Assets	10.05	11.96	9.25	13.9	12.04
Return on Total Capital	15.05	17.03	13.14	19.62	16.28
Return On Equity %	38.82	34.46	0.9	40.79	36.88
Return on Common Equity	38.88	34.5	0.87	40.81	36.91
Margin Analysis
Gross Profit Margin %	72.81	70.98	73.53	77.09	77.21
SG&A Margin	19.31	16.31	16.44	15.74	15.56
EBITDA Margin %	38.97	41.08	32.78	45.4	44.77
EBITA Margin %	35.92	38.21	29.97	42.52	41.93
EBIT Margin %	32.56	34.69	26.57	38.79	37.64
Income From Continuing Operations Margin %	25.37	24.5	0.63	26.7	28.09
Net Income Margin %	26.79	24.49	0.61	26.68	28.08
Net Avail. For Common Margin %	25.35	24.49	0.61	26.68	28.08
Normalized Net Income Margin	19.28	21.29	15.83	23.44	22.42
Levered Free Cash Flow Margin	13.69	21.41	15.41	27.79	18.28
Unlevered Free Cash Flow Margin	14.73	22.42	16.6	29.02	19.59
Asset Turnover
Asset Turnover	0.49	0.55	0.56	0.57	0.51
Fixed Assets Turnover	2.46	2.72	2.54	2.59	2.5
Receivables Turnover (Average Receivables)	5.41	5.54	5.39	5.78	5.46
Inventory Turnover (Average Inventory)	2.3	2.9	2.59	2.36	2.32
Short Term Liquidity
Current Ratio	1.27	1.47	1.25	1.36	1.54
Quick Ratio	0.79	0.98	0.73	0.87	0.96
Operating Cash Flow to Current Liabilities	0.59	0.79	0.51	0.76	0.58
Days Sales Outstanding (Average Receivables)	67.52	65.88	67.78	63.29	66.84
Days Outstanding Inventory (Average Inventory)	158.6	125.84	140.69	155.22	157.27
Average Days Payable Outstanding	147.9	121.49	112.98	119.47	113.01
Cash Conversion Cycle (Average Days)	78.22	70.23	95.49	99.04	111.1
Long Term Solvency
Total Debt/Equity	90.52	69.44	96.37	82.53	95.96
Total Debt / Total Capital	47.51	40.98	49.08	45.21	48.97
LT Debt/Equity	83.42	64.61	91.96	76.21	90.48
Long-Term Debt / Total Capital	43.79	38.13	46.83	41.75	46.18
Total Liabilities / Total Assets	63.8	57.81	64.72	60.4	61.52
EBIT / Interest Expense	19.67	21.38	13.94	19.58	18.03
EBITDA / Interest Expense	23.97	25.66	17.49	23.2	21.76
(EBITDA - Capex) / Interest Expense	18.46	21.1	14.12	20.54	18.73
Total Debt / EBITDA	1.79	1.3	1.81	1.3	1.71
Net Debt / EBITDA	1.37	0.76	1.46	0.83	1.22
Total Debt / (EBITDA - Capex)	2.33	1.58	2.24	1.47	1.99
Net Debt / (EBITDA - Capex)	1.78	0.93	1.8	0.94	1.42
Growth Over Prior Year
Total Revenues, 1 Yr. Growth %	17.31	21.72	1.4	6.74	1.31
Gross Profit, 1 Yr. Growth %	18.36	19.53	5.05	11.92	1.47
EBITDA, 1 Yr. Growth %	31.26	31.13	-18.84	47.84	-0.1
EBITA, 1 Yr. Growth %	33.95	32.57	-20.19	51.43	-0.09
EBIT, 1 Yr. Growth %	41.05	33.12	-22.04	55.81	-1.7
Earnings From Cont. Operations, 1 Yr. Growth %	173.23	17.54	-97.4	4.44T	6.6
Net Income, 1 Yr. Growth %	84.65	11.27	-97.49	4.59T	6.64
Normalized Net Income, 1 Yr. Growth %	43.8	38.14	-24.33	58.12	-3.12
Diluted EPS Before Extra, 1 Yr. Growth %	173.03	17.49	-97.55	4.71T	8.01
Accounts Receivable, 1 Yr. Growth %	48.88	-1.47	10.2	0.42	14.14
Inventory, 1 Yr. Growth %	7.18	-0.71	7.56	-3.92	8.99
Net Property, Plant and Equip., 1 Yr. Growth %	11.65	9.12	7.55	2.7	6.66
Total Assets, 1 Yr. Growth %	15.4	3.28	-2.28	9.78	16.87
Tangible Book Value, 1 Yr. Growth %	-21.56	-175.14	-136.01	-608.6	-47.48
Common Equity, 1 Yr. Growth %	50.82	20.45	-18.29	23.24	13.59
Cash From Operations, 1 Yr. Growth %	37.77	35.34	-31.89	65.06	-23.27
Capital Expenditures, 1 Yr. Growth %	0.43	-1.35	-11.96	-12.71	21.95
Levered Free Cash Flow, 1 Yr. Growth %	26.09	98.28	-26.75	92.51	-33.33
Unlevered Free Cash Flow, 1 Yr. Growth %	23.49	92.52	-24.66	86.65	-31.62
Dividend Per Share, 1 Yr. Growth %	6.56	6.15	5.8	5.48	5.19
Compound Annual Growth Rate Over Two Years
Total Revenues, 2 Yr. CAGR %	11.58	19.49	11.1	4.04	3.99
Gross Profit, 2 Yr. CAGR %	12.42	19.37	12	8.43	6.57
EBITDA, 2 Yr. CAGR %	17.64	33.75	7.61	9.54	21.53
EBITA, 2 Yr. CAGR %	19.1	36.19	7.72	9.94	23
EBIT, 2 Yr. CAGR %	22.09	40.65	7.23	10.21	23.76
Earnings From Cont. Operations, 2 Yr. CAGR %	48.47	79.21	-82.53	8.6	596.01
Net Income, 2 Yr. CAGR %	15.14	43.33	-83.28	8.58	607.18
Normalized Net Income, 2 Yr. CAGR %	22.03	45.02	7.96	9.38	23.76
Diluted EPS Before Extra, 2 Yr. CAGR %	48.29	79.11	-83.03	8.65	621.11
Accounts Receivable, 2 Yr. CAGR %	23.17	21.12	4.2	2.32	7.06
Inventory, 2 Yr. CAGR %	-0.21	3.16	3.35	1.66	2.33
Net Property, Plant and Equip., 2 Yr. CAGR %	13.75	10.38	8.33	5.1	4.66
Total Assets, 2 Yr. CAGR %	11.91	9.17	0.46	3.58	13.27
Tangible Book Value, 2 Yr. CAGR %	-11.71	-23.23	-47.98	35.34	63.44
Common Equity, 2 Yr. CAGR %	21.4	34.78	-0.79	0.35	18.31
Cash From Operations, 2 Yr. CAGR %	2.46	36.55	-3.99	6.03	12.54
Capital Expenditures, 2 Yr. CAGR %	14.9	-0.46	-6.81	-12.34	3.17
Levered Free Cash Flow, 2 Yr. CAGR %	-6.57	63.29	30.63	18.75	13.29
Unlevered Free Cash Flow, 2 Yr. CAGR %	-6.46	58.68	29.7	18.58	12.97
Dividend Per Share, 2 Yr. CAGR %	8.71	6.36	5.98	5.64	5.34
Compound Annual Growth Rate Over Three Years
Total Revenues, 3 Yr. CAGR %	4.82	14.86	13.13	9.63	3.12
Gross Profit, 3 Yr. CAGR %	7.01	14.46	14.39	11.97	6.06
EBITDA, 3 Yr. CAGR %	9.08	21.09	13.12	19.63	6.23
EBITA, 3 Yr. CAGR %	9.83	22.46	13.84	20.67	6.49
EBIT, 3 Yr. CAGR %	16.22	24.57	15.4	21.45	6.09
Earnings From Cont. Operations, 3 Yr. CAGR %	25.9	37.35	-56.32	11.51	7.93
Net Income, 3 Yr. CAGR %	28.02	13.83	-62.76	9.47	7.93
Normalized Net Income, 3 Yr. CAGR %	15.78	26.02	16.61	22.6	5.04
Diluted EPS Before Extra, 3 Yr. CAGR %	27.95	37.22	-57.15	11.52	8.43
Accounts Receivable, 3 Yr. CAGR %	14.26	14.34	17.36	1.04	6.12
Inventory, 3 Yr. CAGR %	3.05	-0.38	4.61	0.87	4.05
Net Property, Plant and Equip., 3 Yr. CAGR %	16.22	12.18	9.43	6.42	5.62
Total Assets, 3 Yr. CAGR %	8.55	8.95	5.21	3.48	7.83
Tangible Book Value, 3 Yr. CAGR %	8.9	-16.33	-40.35	11.23	-1.29
Common Equity, 3 Yr. CAGR %	12.66	21.08	14.07	6.64	4.58
Cash From Operations, 3 Yr. CAGR %	8.91	12.42	8.29	15.02	-4.81
Capital Expenditures, 3 Yr. CAGR %	19.37	9.21	-4.46	-8.82	-2.14
Levered Free Cash Flow, 3 Yr. CAGR %	-8.43	18.43	24.85	48.66	-2.04
Unlevered Free Cash Flow, 3 Yr. CAGR %	-7.86	17.48	23.64	46.43	-1.3
Dividend Per Share, 3 Yr. CAGR %	10.63	7.85	6.17	5.81	5.49
Compound Annual Growth Rate Over Five Years
Total Revenues, 5 Yr. CAGR %	4.12	8.12	7.29	10.4	9.38
Gross Profit, 5 Yr. CAGR %	6.16	8.95	8.84	12.01	11.2
EBITDA, 5 Yr. CAGR %	4.38	14.06	6.15	16.26	16.41
EBITA, 5 Yr. CAGR %	4.75	15.12	6.41	17.21	17.42
EBIT, 5 Yr. CAGR %	9.5	20.78	9.6	18.53	18.67
Earnings From Cont. Operations, 5 Yr. CAGR %	25.68	43.13	-42.87	25.04	32.2
Net Income, 5 Yr. CAGR %	27.19	43.4	-43.28	11.7	20.9
Normalized Net Income, 5 Yr. CAGR %	9.18	20.99	9.47	18.99	19.42
Diluted EPS Before Extra, 5 Yr. CAGR %	28.08	45.69	-42.97	24.98	32.54
Accounts Receivable, 5 Yr. CAGR %	8.96	8.95	10.13	9.37	11.88
Inventory, 5 Yr. CAGR %	4.11	3.01	3.17	0.43	3.69
Net Property, Plant and Equip., 5 Yr. CAGR %	11.65	12.85	13	9.29	7.5
Total Assets, 5 Yr. CAGR %	2.08	4.43	5.24	6.77	8.37
Tangible Book Value, 5 Yr. CAGR %	5.41	19.31	-18.96	1.41	-10.73
Common Equity, 5 Yr. CAGR %	-0.97	6.02	7.08	12.32	15.75
Cash From Operations, 5 Yr. CAGR %	6.34	24.24	3.55	9.82	9.97
Capital Expenditures, 5 Yr. CAGR %	22.48	18.37	8.12	0.02	-1.47
Levered Free Cash Flow, 5 Yr. CAGR %	-7.53	14.34	1.29	18.47	20.09
Unlevered Free Cash Flow, 5 Yr. CAGR %	-6.97	13.8	1.71	17.83	19.26
Dividend Per Share, 5 Yr. CAGR %	7.16	7.98	8.75	6.96	5.84